Introduction
The role of the mitochondrial membrane potential (DC m ) in apoptosis remains unclear, mostly due to the dierent model systems used. Cells devoid of mitochondrial (mt)DNA (r 0 cells) can still undergo apoptosis induced by staurosporine (Jacobson et al., 1993; Jiang et al., 1999) , anti-Fas antibodies (Gamen et al., 1995) , tumour necrosis factor-a plus cycloheximide , or didemnin B (this paper) indicating that there is no general breakdown in apoptotic signalling in cells lacking a functional electron transport chain. Mitochondria have however been implicated in apoptosis through the release of several proteins during the onset of apoptosis; these include AIF (Susin et al., 1999) , Apaf-1 (Zou et al., 1997) , caspase-9 (Li et al., 1997; Krajewski et al., 1999) as well as cytochrome c (Liu et al., 1996; Kluck et al., 1997a; Yang et al., 1997) . Cytochrome c release appears to occur upstream of caspase-3 activation, and to be necessary for caspase-9 induced activation of caspase-3 (Li et al., 1997; Kluck et al., 1997b; Slee et al., 1999) .
There has been some debate as to the mechanism of cytochrome c release from mitochondria during apoptosis. Direct rupture of the outer mitochondria membrane via activation of the mitochondrial permeability transition pore (PTP; Scarlett and Murphy, 1997) has been suggested as a possible route of escape, however, cytochrome c release has been reported to occur prior to any mitochondrial membrane breakage (Zhuang et al., 1998) . The PTP operates in three distinct states: a closed state with intact DC m , a lowconductance state, where the pore is only permeable to molecules 5300 Da and DC m decreases reversibly, and ®nally the classic high-conductance state in which the pore is permeable to molecules 51500 Da. This latter state leads to the irreversible collapse of DC m due to rupture of the outer mitochondrial membrane (Ichas and Mazat, 1998) , and it is this state which had originally been suggested to be an early necessary step in apoptosis (Zamzami et al., 1995a . Inhibition of the PTP with bongkrekic acid (BA), a potent inhibitor of the adenine nucleotide translocator, can lead to inhibition of dexamethasone-induced apoptosis . Another inhibitor of the PTP, cyclosporin A (CyA) can inhibit PTP function (Fournier et al., 1987) through binding to mitochondrial cyclophilin D (Petronilli et al., 1993) , and consequently, can inhibit apoptosis in several systems (Zamzami et al., 1995a . Furthermore, permeability transition (PT) has been demonstrated to be involved in the release of AIF from mitochondria during dexamethasone-induced apoptosis (Susin et al., 1999) . A comprehensive review on the various hypotheses presently discussed for the mechanism of cytochrome c release can be found in Desagher and Martinou (2000) .
Didemnin B is a cyclic branched peptolide described to have potent anti-neoplastic (Rinehart et al., 1983), anti-viral (Weed and Stringfellow, 1983) , and immunosuppressive (Montgomery and Zukoski, 1985) properties. The biological action of didemnin B is obscure, however, didemnin B may interact with elongation factor 1a (Crews et al., 1994) , and a palmitoyl thioesterase (Crews et al., 1996; Meng et al., 1998) . We have previously shown that didemnin B induces extremely rapid apoptosis in unsynchronized cultures of the human pro-myeloid cell line HL-60, with all cells displaying morphological characteristics of apoptosis within about 3 h (Grubb et al., 1995) . This extremely rapid and complete induction can be inhibited by preincubation of the cells with Zn 2+ (Grubb et al., 1995) , tyrosine kinases inhibitors (Johnson et al., 1996) , z-VAD-fmk or by rapamycin . Didemnin B-induced apoptosis is not restricted to HL-60 cells, and has been described to induce apoptosis in human lymphoblastoid Daudi cells . We have since used the drug to induce apoptosis in a wide range of mammalian cell lines including human lymphoblastoid Jurkat and MOLT-4, human melanoma MM96, SK-MEL-3 and SK-MEL-28, and human cervical cancer-derived HeLa cells.
Since the induction of apoptosis by didemnin B is a very fast event in HL-60 cells, we have used this system to study the minimal requirements for apoptosis to occur. In this paper we analyse the involvement of mitochondrial functions in the apoptotic process, and demonstrate that didemnin B-induced apoptosis does not require mitochondrial permeability transition for release of mitochondrial cytochrome c, an event which appears to be totally caspase-dependent in the system studied.
Results

Mitochondrial membrane potential and permeability transition
It has been suggested , that apoptosis requires the mitochondria to undergo highconductance PT, a process which concomitantly proceeds with irreversible loss of mitochondrial membrane potential (DC m ). We sought to use our system of didemnin B-induced apoptosis in HL-60 cells to analyse the requirements for PT and DC m dissipation during apoptosis, and, to compare cells depleted in mitochondrial DNA (and hence lacking an intact electron transport chain; r 0 ) with their wild type r + parental cells. We decided to use the mitochondrial dye JC-1, which is a more reliable¯uorescent probe than either 3,3'dihexyloxacarbocyanine iodide [DiOC 6 (3)] or rhodamine 123 for measuring DC m in intact cells (Salvioli et al., 1997) . JC-1 monomers, which emit at 538 nm when excited at 488 nm, are sequestered due to their charge into respiring mitochondria, where the monomers form J-aggregates which emit at 590 nm when excited at 488 nm. The DC m for the r 0 cells was 60.6+3% that of r + cells. When incubated with 1 mM didemnin B, r 0 HL-60 cells underwent apoptosis at a similar rate to the r + parental strain (Figure 1 ). Complete apoptosis (100% of cells displaying apoptotic morphology) was observed by 3.5 h. These data show that the lower DC m of r 0 cells does not predispose these cells to undergo more rapid apoptosis than the parental cells upon exposure to didemnin B.
Cells loaded with JC-1 and continuously treated with 1 mM didemnin B show a decrease in DC m between 1 and 2 h of treatment as determined by¯uorescent spectrophotometric analysis (Figure 2 ). CCCP, an agent which rapidly dissipates the DC m , was used at a concentration of 50 mM, to determine the¯uorescence of completely depolarized mitochondria and such gave a baseline for the experiments. To verify these observations, and the assay system, HL-60 cells were also treated with 1 mM didemnin B prior to the addition of the DiOC 6 (3), and then analysed by FACS analysis. The use of a completely dierent analysis technique revealed that decreases in DC m are relatively early events (clearly visible after 1 h) in didemnin Binduced apoptosis (Figure 3) , and not dependent on PT. The gradual loss of DC m observed in didemnin Btreated HL-60 cells occurs before the onset of any signi®cant morphological apoptosis. Pre-incubation of HL-60 cells with 100 mM z-VAD-fmk prior to the addition of didemnin B, completely inhibits the morphological appearance of apoptosis and the decline in DC m (data not shown).
The human lymphoblastoid Daudi cell line was used to determine if the eects seen in HL-60 cells were cell line speci®c. Since the kinetics of didemnin B-induced apoptosis in Daudi cells has been reported to be slower than in HL-60 cells We also tested bongkrekic acid (BA), an inhibitor of the adenine nucleotide translocase which has been associated with PT (Henderson and Lardy, 1970; Klingenberg et al., 1970) , and unlike CyA, is not known to have non-mitochondrial anti-apoptotic side eects. Fifty mM BA or the vehicle [1.6 mM (NH 4 ) 2 SO 4 ] had no detectable eects on HL-60 cells. Pre-incubation of HL-60 cells with BA for 30 min prior to the addition of didemnin B had no signi®cant eect on the induction of apoptosis as judged by morphology and DNA fragmentation (Figure 5 ), or on the DC m over the time course of the experiment (data not shown).
Electron microscopic examination of r + HL-60 cells before and after treatment with 1 mM didemnin B revealed the presence of intact mitochondria in control cells. Cells treated for 3 h with didemnin B showed mitochondria, which are not grossly swollen, and have apparently intact membranes. However, these mitochondria appear to have a disorganized internal membrane arrangement, indicating that there are mitochondrial changes occurring as a result of didemnin B treatment ( Figure 6 ).
As 1 mM CyA had no eect on didemnin B-induced apoptosis, it was important to determine that 1 mM CyA could aect closure of the PTP, and protect against mitochondrial depolarization under the experimental conditions used. We therefore established an assay to assess PT in vivo. This assay measured mitochondrial Ca 2+ using the¯uorophore Rhod-2-AM as described in Material and methods. HL-60 mitochondria were analysed for their ability to cope with a transient rise in cytosolic Ca 2+ induced with 10 mM thapsigargin. Compared to the control HL-60 cells, incubation with 1 mM didemnin B for up to 4 h did not signi®cantly lower mitochondrial Rhod-2 uorescence after thapsigargin treatment. Pre-treatment of cells for 30 min with 1 mM CyA induced a transient peak in mitochondrial Ca 2+¯u orescence at time zero (Table 1 ), suggesting that CyA is inhibiting PT at this concentration, by inhibiting the eux of mitochondrial Ca
2+
. A similar eect was observed when cells were incubated with both CyA and didemnin B (Table 1) .
Didemnin B-induced cytochrome c release
Mitochondria have also been deemed to play a central role in apoptosis by releasing several`apoptotic factors' Mitochondrial Ca 2+ was determined using Rhod-2 AM as described in Materials and methods after the addition of 10 mM thapsigargin. HL-60 cells loaded with Rhod-2AM, but not treated with thapsigargin were given the arbitrary value of zero. HL-60 cells were preated with 1 mM CyA, 1 mM didemnin B, or both for 30 min prior to the addition of thapsigargin. The data represent the mean of three experiments+standard deviation into the cytosol during apoptosis. AIF (Susin et al., 1999) , Apaf-1 (Zou et al., 1997) , caspase-9 (Li et al., 1997) and cytochrome c (Kluck et al., 1997a) have all been reported to be released during apoptosis, possibly via outer mitochondrial membrane breakage caused by opening of the PTP (Scarlett and Murphy, 1997) . HL-60 cells incubated with 1 mM didemnin B showed rapid and total translocation of cytochrome c from the mitochondria to the cytosol (Figure 7a,b) . Pre-incubation with CyA or BA, which had no inhibitory eect on didemnin B-induced apoptosis, also had no inhibitory eect on didemnin B-induced cytochrome c release from the mitochondria (Figure 7c ± e). Western blots for cytochrome c show that didemnin B induces the release of cytochrome c from the mitochondria into the cytosol over a time course, which corresponds with induction of both morphological apoptosis and DNA fragmentation. Cytochrome c is ®rst observed in the cytosol after 2 h incubation with didemnin B, which is 2 h prior to any signi®cant change in DC m .
We have shown elsewhere ) that didemnin B-induced apoptosis is not sensitive to the inhibitor of caspase-1 Ac-YVAD-cmk, or the caspase-3 inhibitor, Ac-DEVD-cho. These two peptide inhibitors also had no eect on didemnin B-induced release of cytochrome c into the cytosol (Figure 8c,d) . The general caspase inhibitor z-VAD-fmk on the other hand, completely inhibits apoptosis induced by 1 mM didemnin B in HL-60 cells , and the didemnin B-induced appearance of cytosolic cytochrome c in HL-60 cells (Figure 8b ). Didemnin B-induced apoptosis in the human melanoma cell line MM96, which shows similar kinetics of induction of apoptosis to HL-60 cells (data not shown), also results in the early release of cytochrome c (Figure 9 ). Like HL-60 cells, pre-incubation of MM96 cells with Figure 3 Eect of the PT inhibitor CyA on the dissipation of DC m during didemnin B-induced apoptosis in HL-60 cells. DC m was determined as described in Materials and methods using the mitochondrial marker DiOC 6 (3) in the presence of ethanol, 1 mM didemnin B, 1 mM CyA, 1 mM didemnin B+1 mM CyA. Fifty mM CCCP was used to determine the¯uorescence of fully depolarized mitochondria. Samples were analysed by¯ow cytometry, excitation at 488 nm, and the resulting emission was recorded at 530 nm 100 mM z-VAD-fmk prior to the addition of 1 mM didemnin B, protects MM96 cells from undergoing morphological apoptosis, and inhibits mitochondrial cytochrome c release (Figure 9 ), indicating that this phenomenon is not restricted to HL-60 cells. The inhibition of cytochrome c release by z-VAD-fmk was also not restricted to didemnin B-induced apoptosis. One hundred mM z-VAD-fmk inhibits both the onset of apoptosis, and mitochondrial cytochrome c release induced by 70 mM etoposide (Figure 10 ). These data suggest that the caspase-dependent release of cytochrome c is not restricted to didemnin B-induced apoptosis. The release of cytochrome c into the cytosol is known to lead to the activation of eector caspases, possibly via the formation of the apoptosome complex with pro-caspase-9 (Slee et al., 1999) .
Discussion
Comparison of the time course for irreversible loss of DC m with the appearance of morphological apoptosis, DNA fragmentation and cytochrome c release, suggests that DC m change occurs concurrently with a number of apoptosis associated events in HL-60 cells upon didemnin B-treatment. This is in general agreement with a number of previous reports on DC m changes during apoptosis (Kluck et al., 1997b; Bossy-Wetzel et al., 1998; Krohn et al., 1999) . Work by Zamzami et al. (1995b) has suggested that cells which have a lowered DC m could be induced to more readily undergo apoptosis than the same cell type with a high DC m . The use of r 0 cells provides some evidence that this is not the case for HL-60 cells undergoing didemnin Binduced apoptosis. It is interesting to note that during didemnin B-induced apoptosis, the DC m decreases to a level comparable to r 0 viable cells. Therefore, our results strongly imply that DC m is not a determining factor in didemnin B-induced apoptosis.
There were no signi®cant thapsigargin induced Rhod-2¯uorescence changes between control cells, and cells treated for up to 4 h with 1 mM didemnin B, suggesting that PT must still be regulated in cells undergoing didemnin B-induced apoptosis. The ability to regulate PT even after the release of mitochondrial cytochrome c suggests that the inner mitochondrial membrane remains intact during apoptosis. These observations allow for the possibility of cytochrome c release through the formation of Bax containing pores in the outer mitochondrial membrane (Saito et al., 2000) . Cytochrome c has also been suggested to be released through the formation of ANT/Bax complexes (Brenner et al., 2000) . This pore would span both the inner and outer mitochondrial membranes, and lead to a rapid and complete loss of DC m ; however, our data do not support this idea, or the direct rupture of the (Scarlett and Murphy, 1997) .
Caspases have been reported to play a role in the dissipation of DC m (Zhai et al., 2000) during apoptosis. The actual mechanism whereby didemnin B-induces the decrease in DC m remains obscure. We have earlier shown ) that didemnin B-induced apoptosis in HL-60 cells can be blocked by z-VADfmk. As well, the decrease in DC m can be suppressed by zVAD-fmk, thus suggesting that caspases play a role in the degeneration of DC m during didemnin Binduced apoptosis when induced to undergo apoptosis by didemnin B or etoposide. How caspases eect DC m remains obscure; however cytochrome c release is caspase dependent in HL-60 and MM96 cells. One possibility may be that the physical translocation of cytochrome c out of the mitochondria leads to the disruption of proton pumping by the mitochondrial electron transport chain. Others have previously reported on the contribution of caspases to the release of cytochrome c (Chen et al., 2000; Rytomaa et al., 2000; Robertson et al., 2000) ; however, in our system, cytochrome c release can be completely blocked by z-VAD-fmk. These results are in contrast to data by Goldstein et al. (2000) , where the authors could not inhibit cytochrome c release from HeLa cells by z-VAD-fmk upon actinomycin, staurosporine, or UVexposure. On the other hand, these authors see, like us, complete inhibition of cytochrome c release upon exposure to tumour necrosis factor.
The results presented here are consistent with previous observations (Bossy-Wetzel et al., 1998; Figure 7 Release of cytochrome c from cells treated with 1 mM didemnin B. HL-60 cells were treated with 1 mM didemnin B and samples were collected at 0, 2 and 4 h (a). Release of cytochrome c was determined by Western blot as described in Materials and methods. Five mM Staurosporine was used as a positive control for cytochrome c release (b). To determine the eect of PT inhibitors on cytochrome c release in HL-60 cells, cells were pre-treated for 30 min with 0.1% (v/v) ethanol (c), 1 mM CyA (d) or 50 mM BA (e) prior to addition of 1 mM didemnin B. Western blots were preformed as described in Materials and methods. Samples were collected at zero, 2 h and 4 h after addition of didemnin B. Control lanes (C1, C2 and C3) represent cells incubated with vehicle (ethanol or NH 4 OH) alone Figure 8 Eect of caspase inhibitors on didemnin B-induced cytochrome c release. HL-60 cells were pre-treated as described with 0.1% (v/v) DMSO (a), 100 mM z-VAD-fmk (b), 300 mM Ac-YVAD-cmk (c), or 300 mM Ac-DEVDcho (d) prior to addition of 1 mM didemnin B. Western blots were preformed as described in Materials and methods. Control lanes represent cells incubated with vehicle (DMSO) alone Figure 9 Eect of caspase inhibitor z-VAD-fmk on didemnin Binduced cytochrome c release in MM96 cells. MM96 cells were pre-treated as described with either 0.1% (v/v) DMSO or 100 mM z-VAD-fmk prior to addition of 1 mM didemnin B. Western blots were preformed as described in Materials and methods on gels containing either mitochondrial fraction (a), or cytosolic fraction (b) Krohn et al., 1999) , in that loss of DC m is not a prerequisite for either mitochondrial cytochrome c release, or apoptosis. However, in these systems PT was not inhibited, and thus may still have played a role in the induction of apoptosis. By the use of the potent PT inhibitors CyA and BA, we show that neither PT nor, a functional PTP is required for didemnin B-induced apoptosis. These data are similar to data reported on Bid-induced cytochrome c release (Kim et al., 2000) .
Apoptotic signalling via the mitochondria appears to occur via several distinct pathways. Apoptosis may be dependent on the induction of PT for the mitochondrial release of cytochrome c, and thus can be inhibited with inhibitors of the PTP, such as CyA (Scorrano et al., 1999) . Or signalling may be independent of PT, and cytochrome c release is dependent on caspases (Kirsch et al., 1999) , or Bid (Slee et al., 2000) . The results presented here for didemnin B-induced apoptosis in HL-60 cells are consistent with apoptotic signalling via a PT independent, caspase dependent pathway, as the decrease in DC m observed during didemnin B-induced apoptosis is not inhibitable by the PT-inhibitors CyA and BA, but can be completely inhibited by z-VADfmk. This suggests that PT is not a determining factor in DC m dissipation during didemnin B-induced apoptosis.
The general caspase inhibitor z-VAD-fmk is a potent inhibitor of didemnin B-induced apoptosis and cytochrome c release in all the cell lines tested (HL-60, Daudi, MM96), indicating a role for caspases in the mitochondrial release of cytochrome c. The inhibition of etoposideinduced cytochrome c release indicates that the caspase-dependent release of cytochrome c is not restricted to didemnin B-induced apoptosis. The more speci®c caspase inhibitors Ac-DEVD-cho, Ac-YVADcmk and Ac-LEHD-cho have no inhibitory eect on didemnin B-induced apoptosis in HL-60 cells. This suggests that caspases-1, -3 and -9 are not important signalling intermediates for didemnin B-induced apoptosis in this cell line . Neither Ac-DEVD-cho, Ac-YVAD-cmk or Ac-LEHD-cho showed any protective eect against cytochrome c release or had any eect on DC m , which is consistent with previous observations (Pastorino et al., 1998) . As caspase-3 appears to act downstream of cytochrome c release (Li et al., 1997; Kluck et al., 1997a,b) , its inhibition by Ac-DEVD-cho should not eect cytochrome c release. Western blot analysis for procaspase-9 in subcellular fractions collected from HL-60 cells treated with the vehicle, ethanol for 3 h revealed that pro-caspase-9 localizes with cytochrome c and the mitochondrial porin protein, to a subcellular fraction enriched in mitochondria and membranes. However, HL-60 cells incubated for 3 h with 1 mM didemnin B show the movement of caspase-9 from the membrane-enriched fraction into the cytosolic fraction (data not shown). Previous reports of the localization and release of pro-caspase-9 from the mitochondria (Krajewski et al., 1999 ) support our observations (data not shown), which suggest that pro-caspase-9 is present in the mitochondria and released into the cytosol upon didemnin B treatment. While didemnin B-induced apoptosis in HL-60 cells is dependent on caspase activation, this(ese) caspase(s) appear to be active upstream from mitochondria. Doxorubicininduced apoptosis, cytochrome c release and DC m changes in Jurkat cells also require the activation of caspases upstream from the mitochondria (Gamen et al., 2000) . However, Ac-DEVD-cho and Ac-LEHDcho both inhibit apoptosis, cytochrome c release and DC m dissipation caused by doxorubicin, which is not evident in didemnin B-induced apoptosis. Recent observations that the cleavage of Bid by caspase-8 can lead to the mitochondrial release of cytochrome c (Zhai et al., 2000) , suggest that the release of cytochrome c from the mitochondria may occur via the interaction of Bid with mitochondrial surface proteins such as Bax.
In conclusion, our data suggest that didemnin Binduced apoptosis is a caspase dependent process, which does not require permeability transition to induce DC m dissipation, and the mitochondrial release of cytochrome c and caspase-9 but may involve Bid in its signalling pathway.
Materials and methods
Cell lines and culture
The human leukaemia cell lines HL-60 and Daudi, and the human melanoma cell line MM96 were maintained in RPMI 1640 medium (Gibco, Melbourne, Australia), and supplemented and cultured as described (Grubb et al., 1995; Johnson et al., 1996) . Cells were passaged three times weekly. Didemnin B (kind gift of NIH, Bethesda, USA) and etoposide (SigmaAldrich, Castle Hill, Australia) were dissolved in ethanol, and were added to cultures at a ®nal concentration of 1 mM and 70 mM respectively (2.5 to 3.5610 5 viable cells/ml as determined by Trypan blue exclusion). Where indicated, cells Figure 10 Eect of caspase inhibitor z-VAD-fmk on etoposideinduced cytochrome c release in HL-60 cells. HL-60 cells were pre-treated as described with either 0.1% (v/v) DMSO or 100 mM z-VAD-fmk prior to addition of 70 mM etoposide. Western blots were preformed as described in Materials and methods on gels containing either mitochondrial fraction (a), or cytosolic fraction (b) were also pre-incubated for 30 min with either 1 mM cyclosporin A (CyA) dissolved in ethanol or 50 mM bongkrekic acid (BA; Lijmbach et al., 1970; de Bruijn et al., 1973) , dissolved in 1.6 mM NH 4 OH. Peptide caspase inhibitors were used as described elsewhere .
Cells devoid of mitochondrial DNA (r 0 ) were generated as described previously (Larm et al., 1994; Vaillant and Nagley, 1995) . The presence of mtDNA was analysed by PCR using mtDNA speci®c primers (Vaillant and Nagley, 1995) . The two primer pairs used were H15680-L14820 and H3728-L2826, which gives rise to an 861 bp and 903 bp fragment respectively. Measurement of cytochrome c oxidase activity was carried out as described (Vaillant and Nagley, 1995) . HL-60 r 0 clones were selected on the bases of having no detectable cytochrome c oxidase activity, or detectable mtDNA.
Western blots
For Western blots to detect cytochrome c, 3610 6 cells were suspended in 0.8 ml of homogenization buer (20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 250 mM sucrose, 100 mg/ ml digitonin, 1 mM PMSF, 10 mg/ml aprotinin, 10 mg/ml leupeptin). Cells were incubated on ice for 3 min then dounced on ice at a rate of one stroke/second for two min. Samples were centrifuged at 25 000 g for 20 min at 48C. Supernatant was collected, and the pellet resuspended in 200 ml homogenization buer. Protein concentration was determined as described (Bradford, 1976) , and total protein was precipitated with 10% TCA. Precipitated protein was collected by centrifugation at 10 000 g for 15 min at 48C. The pellets were resuspended in 0.4 M NaOH to give a ®nal protein concentration of 1 mg/ml. Fifteen mg of protein were loaded per lane, and separated in polyacrylamide gels by electrophoresis, transferred to nitrocellulose, and probed using mouse monoclonal anti-cytochrome c antibody (PharMingen, San Diego, CA, USA). Blots were developed using ECL (Amersham Life Science, Buckinghamshire, England) before exposure to X-ray ®lms (Fuji Photo Film Co. Ltd., Tokyo, Japan).
Morphological determination of apoptosis
At the times indicated, 200 ml samples of the cell culture were collected for determination of apoptosis as described previously (Grubb et al., 1995; Johnson et al., 1996) . Nuclear morphology was determined using 0.1 mg/ml 4',6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, Castle Hill, Australia) as described (Russel et al., 1975) . The slides were observed under a¯uorescence microscope at an excitation wavelength of 280 nm. The percentage of apoptotic nuclei was determined by counting more than 400 cells from at least three separate determinations each. The percentages of apoptotic cells are presented as averages+standard deviation.
DNA fragmentation assays
Cells were grown and treated as above. A total of 2610 6 cells/sample was lysed and treated as described (Herrmann et al., 1994) , before DNA fragments were separated by agarose gel electrophoresis in 1.8% gels.
Measurement of mitochondrial membrane potential
Thirty minutes prior to each time point 3 mM 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1; Molecular Probes, Eugene, OR, USA) dissolved in ethanol, was added to 1610 6 cells/ml. Cells were then pelleted, resuspended in phosphate buered saline at room temperature, and the¯uorescence was then determined using a Hitachi F-4000¯uorescence spectrophotometer. To determine the`green ± red' ratio of low energy mitochondria to high energy mitochondria, samples were excited at 488 nm, and the¯uorescent units (FU) recorded at 535 nm and 590 nm. The ratio was determined by dividing the FU at 590 nm by the FU at 535 nm. All values are expressed as the average of six independent experiments+standard deviation. Carbonyl cyanide m-chlorophenyl hydrazone (CCCP; SigmaAldrich, Castle Hill, Australia) was used at a concentration of 50 mM as a positive control for membrane depolarization.
Flow cytometry was performed as follows: 1610 6 cells were treated with either 1 mM didemnin B, 1 mM CyA, 1 mM didemnin B+1 mM CyA or absolute ethanol (vehicle) as described above. At each time point, cells were washed once in PBS, then resuspended in PBS+2% FCS with 50 nM 3,3'-dihexyloxacarbocyanide iodide [DiOC 6 (3) PBS, Molecular Probes, Eugene, OR, USA] for 30 min at 378C, followed by analysis on a¯ow cytometer (FACScan Becton Dickinson, USA). Cell viability was determined by the ability to exclude propidium iodide (5 mg/ml; Sigma Aldrich, Castle Hill, Australia). Forward and side scattering, as well as twō uorescence channels for DiOC 6 (3), and propidium iodide were measured for each sample. Each histogram represents 25 000 events. Control cells incubated for 10 min with 50 mM CCCP were used to determine a basal level for depolarized mitochondria.
Measurement of mitochondrial damage using calcium fluorophores
Prior to use, Rhod-2 acetoxylmethyl ester (Rhod-2 AM) (Molecular Probes, Eugene, OR, USA) was converted to the colourless, non-¯uorescent compound dihydrorhod-2 AM as per the manufacturer's instructions. Esterase cleavage of dihydroRhod-2 AM into dihydroRhod-2 allows it to be sequestered into the mitochondria as a result of a net positive charge. The dihydroRhod-2 is rapidly oxidized into the active calcium¯uorophore Rhod-2 in the mitochondrial environment. The cells to be used were pelleted and resuspended in RPMI-1640 media (non-supplemented) at a concentration of 1610 7 cells/ml at room temperature. DihydroRhod-2 AM was added to a ®nal concentration of 5 mM and incubated with the cells for 25 min at room temperature in the dark. The cells were then washed once in PBS at 378C, then resuspended in supplemented RPMI-1640 media at a concentration of 5610 5 cells/ml and allowed to recover for 2 h prior to the addition of didemnin B. At each time point 3610 6 cells were collected and pelleted by centrifugation. The cell sample was resuspended in 1 ml of PBS at room temperature and read on a¯uorescent spectrophotometer with excitation at 540 nm and emission at 578 nm.
To measure mitochondrial damage, mitochondria in intact control cells or cells induced to undergo apoptosis with didemnin B were tested for their ability to transiently uptake Ca
2+
. The background level of Rhod-2¯uorescence was determined, and then cells were treated with 10 mM thapsigargin (Sigma-Aldrich, Castle Hill, Australia) dissolved in DMSO. The resulting Ca 2+ spike was measured as a function of time and expressed as an increase in Rhod-2 uorescence. To determine if thapsigargin induced Rhod-2 uorescence was due to mitochondrial calcium uptake, cells were pre-treated for either 1 min, 15 min or 2 h, with 1 mM CyA prior to addition of thapsigargin.
Electron microscopic analysis of mitochondria
A total of 3610 6 HL-60 cells treated with didemnin B was harvested and the washed pellet was ®xed with 1.5% glutaraldehyde in phosphate buered saline (PBS) overnight. The ®xed cells were washed three times in PBS, then embedded in 2% agar. The agar block was treated for 1 h at room temperature with osmic acid (1% in 0.1 M cacodylate buer). After dehydration by successive passages in 30, 70, 90 and 100% (v/v) ethanol, the samples were treated overnight in propylene oxide/resin (1 : 1) and embedded in Epon/Araldite resin. Sections were cut and further stained with uranyl acetate and lead citrate prior to examination using a JEOL-100S transmission electron microscope.
Abbreviations AIF, apoptosis inducing factor; CyA, cyclosporin A; BA, bongkrekic acid; JC-1, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide; PT, permeability transition; PTP, permeability transition pore; CCCP, carbonyl cyanide m-chlorophenyl hydrazone; DAPI, 4,6'-diamidino-2-phenylindole; mtDNA, mitochondrial DNA; z-VAD-fmk, benzyloxycarbonyl-Val-Ala-DL-Asp-¯uoro-methylketone; Ac-DEVD-cho, acetyl-Asp-Glu-Val-L-Aspaldehyde; Ac-YVAD-cmk, acetyl-Tyr-Val-Ala-Asp-chloromethylketone
